[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.147.241.171. Please contact the publisher to request reinstatement.
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Article
January 1996

Results of 280 Liver Resections for Hepatocellular Carcinoma

Author Affiliations

From the Departments of Surgery II (Drs Takenaka, Kawahara, Yamamoto, Itasaka, Shirabe, Nishizaki, Yanaga, and Sugimachi) and Pathology II (Drs Kajiyama and Maeda), Faculty of Medicine, Kyushu University, Fukuoka, Japan.

Arch Surg. 1996;131(1):71-76. doi:10.1001/archsurg.1996.01430130073014
Abstract

Objective:  To evaluate the recent results of liver resection in patients with hepatocellular carcinoma.

Design:  Retrospective study.

Setting:  A university hospital in Japan.

Patients:  Two hundred eighty patients who underwent liver resection with complete extirpation of hepatocellular carcinoma from 1985 to 1993.

Main Outcome Measures:  Morbidity and survival after operation and the pathologic features of hepatocellular carcinoma according to the TNM classification of the International Union Against Cancer.

Results:  More than 40% of the patients with stages I and II disease underwent a partial resection of the liver, whereas 50% of those with stages III and IVA were operated on with more than a bisegmentectomy. Fifty percent of all patients had no postoperative complications. The morbidities included intra-abdominal abscess (7%), bile leakage (5%), and hepatic failure (4%, of whom half died; mortality rate, 2%). Histopathologically, 32% of the stage I tumors were well differentiated (grade 1), while, in stage III, 56% had portal invasion and 61% had daughter lesions in the liver. The cumulative survival rates of patients with stages I, II, and III disease and all patients at 5 years were 69%, 52%, 32%, and 50%, respectively, while the disease-free survival rates at 5 years were 38%, 34%, 17%, and 29%, respectively.

Conclusion:  The recent results of liver resection for hepatocellular carcinoma are generally satisfactory; however, the recurrence rate is still high.(Arch Surg. 1996;131:71-76)

References
1.
Kanematsu T, Shirabe K, Sugimachi K,  Surgical strategy for primary hepatocellular carcinoma associated with cirrhosis . Semin Surg Oncol . 1990;6:36-41.Article
2.
Yanaga Y, Kanematsu T, Takenaka K, Matsumata T, Yoshida Y, Sugimachi K.  Hepatic resection for hepatocellular carcinoma in elderly patients . Am J Surg . 1988;155:238-241.Article
3.
Takenaka K, Kanematsu K, Fukuzawa K, Sugimachi K.  Can hepatic failure after surgery for hepatocellular carcinoma in cirrhotic patients be prevented? World J Surg . 1990;14:123-127.Article
4.
Matsumata T, Kanematsu T, Shirabe K, Sonoda T. Furuta T. Sugimachi K.  Decreased morbidity and mortality rates in surgical patients with hepatocellular carcinoma . Br J Surg . 1990;77:677-680.Article
5.
Spiessl B, Beahrs OH, Hermanek P, Hutter RVP, Scheibe O, Wagner O,  Liver . In: Spiessl B, Beahrs OH, Hermanek P, Hutter RVP, Scheibe O, Wagner O, eds. TNM Atlas: Illustrated Guide to the TNM/pTNM Classification of Malignant Tumors . New York, NY: Springer-Verlag; 1989;98-105.
6.
Makuuchi M, Mori T, Gunven P, Yamazaki G, Hasegawa H.  Safety of hemihepatic vascular occlusion during resection of the liver . Surg Gynecol Obstet . 1987;164:155-158.
7.
Andrus CH, Kaminski DL.  Segmental hepatic resection utilizing the ultrasonic dissector . Arch Surg . 1986;121:515-521.Article
8.
Matsumata T, Higashi H, Shimada M, Adachi E, Shirabe K, Sugimachi K.  Indications for major hepatectomy in cirrhotic liver . Hepatogastroenterology . 1994: 41:165-169.
9.
Edmondson HA, Steiner PE.  Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies . Cancer . 1954;7:462-503.Article
10.
Review by an international group: morphological criteria in viral hepatitis. Lancet . 1971;1:333-337.
11.
MacSween RNM.  Pathology of viral hepatitis and its sequelae . Clin Gastroenterol . 1980;9:23-45.
12.
Kaplan EL, Meier P.  Nonparametric estimation from incomplete observation . J Am Stat Assoc . 1958;53:238-241.Article
13.
Nagasue N, Kohno H, Chang YC, et al.  Liver resection for hepatocellular carcinoma: results of 229 consecutive patients during 11 years . Ann Surg . 1993; 217:375-384.Article
14.
Chen MF, Hwang TL, Jeng LB, Wang CS, Jan YY, Chen SC.  Postoperative recurrence of hepatocellular carcinoma: two hundred five consecutive patients who underwent hepatic resection in 15 years . Arch Surg . 1994;129:738-742.Article
15.
Izumi R, Shimizu K, li T, et al.  Prognostic factors of hepatocellular carcinoma in patients undergoing hepatic resection . Gastroenterology . 1994;106:720-727.
16.
Shimada M, Matsumata T, Akazawa K, et al.  Estimation of risk of major complications after hepatic resection . Am J Surg . 1994;167:399-403.Article
17.
Sitzmann JV, Greene PS.  Perioperative predictors of morbidity following hepatic resection for neoplasm: a multivariate analysis of a single surgeon experience with 105 patients . Ann Surg . 1994;219:13-17.Article
18.
Rifkin MD, Rosato FE, Branch HM, et al.  Intraoperative ultrasound of the liver: an important adjunctive tool for decision making in the operating room . Ann Surg . 1987;205:466-472.Article
19.
Yamanaka N, Okamoto E, Oriyama T, et al.  A prediction scoring system to select the surgical treatment of liver cancer: further refinement based on 10 years of use . Ann Surg . 1994;219:342-346.Article
20.
Takenaka K, Shimada M, Higashi H, et al.  Liver resection for hepatocellular carcinoma in the elderly . Arch Surg . 1994:129:846-850.Article
21.
Levraghi T, Salmi A, Bolondi L.  Small hepatocellular carcinoma: percutaneous alcohol injection: results in 23 patients . Radiology . 1988;168:313-317.Article
22.
Ebara M. Kita K, Yoshikawa M, Sugiura N, Ohto M.  Percutaneous ethanol injection for patients with small hepatocellular carcinoma . In: Tobe T, Kameda H, Okudaira M, et al, eds. Primary Liver Cancer in Japan . Tokyo, Japan: Springer-Verlag; 1992;291-300.
23.
Farmer DG, Rosove MH, Shaked A, Busuttil RW.  Current treatment modalities for hepatocellular carcinoma . Ann Surg . 1994;219:236-247.Article
24.
Kotoh K, Sakai H, Sakamoto S, et al.  The effect of percutaneous ethanol injection therapy on small solitary hepatocellular carcinoma is comparable to that of hepatectomy . Am J Gastroenterol . 1994;89:194-198.
25.
Castells A, Bruix J, Bru C, et al.  Treatment of small hepatocellular carcinoma in cirrhotic patients: a cohort study comparing surgical resection and percutaneous ethanol injection . Hepatology . 1993;18:1121-1126.
26.
The Liver Cancer Study Group of Japan.  Primary liver cancer in Japan: clinicopathologic features and results of surgical treatment . Ann Surg . 1990:211: 277-287.
27.
Shirabe K, Kanematsu T, Matsumata T, Adachi E, Akazawa K, Sugimachi K.  Factors linked to early recurrence of small hepatocellular carcinoma after hepatectomy: univariate and multivariate analysis . Hepatology . 1991;14:802-805.Article
28.
Belghiti J, Panis Y, Farges 0, Benhamou JP, Fekete F.  Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis . Ann Surg . 1991;214:114-117.Article
29.
Adachi E. Maeda T, Matsumata T, et al.  Risk factors for intrahepatic recurrence in human hepatocellular carcinoma . Gastroenterology . 1995;108:768-775.Article
30.
Takenaka K. Adachi E, Nishizaki T, et al.  Possible multicentric occurrence of hepatocellular carcinoma: a clinicopathological study . Hepatology . 1994:19: 889-894.Article
31.
Eguchi A, Nakashima O, Okudaira S, Sugihara S, Kojiro M.  Adenomatous hyperplasia in the vicinity of small hepatocellular carcinoma . Hepatology . 1992; 15:843-848.Article
×